Clinical trial

SWITCH: Apixaban vs Vitamin K in HM3

NCT07471139

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhasePHASE3

Study timeline

Study start (estimated)2026-08-01Date precision: month

Registry last updated2026-08-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

LVAD (Left Ventricular Assist Device) Thrombosisunresolved

Heart Failureverified · MONDO: heart failure

Bleedingunresolved

Thrombosis; Arteryunresolved

Strokeverified · MONDO: stroke disorder

Heart Transplantunresolved

Interventions

WarfarinDRUG · verified · RxNorm: warfarin

ApixabanDRUG · verified · RxNorm: apixaban

Sponsors & collaborators

Columbia Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07471139 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.